NCT06696326View on ClinicalTrials.gov

A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 15, 2025

Study Completion Date

October 15, 2025

Conditions
Positron-Emission Tomography(PET)Prostate CancerTrophoblast Cell Surface Antigen 2
Interventions
DIAGNOSTIC_TEST

standard-of-care imaging 68Ga-MY6349 and 68Ga-PSMA-11

Each subject receives a single intravenous injection of standard-of-care imaging radiopharmaceuticals 68Ga-MY6349 and 68Ga-PSMA-11, and undergoes PET/CT imaging within the specified time.

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER